Intravenous tPA (Tissue-Type Plasminogen Activator) in Patients with Acute Ischemic Stroke Taking Non-Vitamin K Antagonist Oral Anticoagulants Preceding Stroke
Stroke 49:2237-2240, Jin, C.,et al, 2018
Implications of the WAKE-UP Trial
Stroke 49:3115-3117, Silver, B. & Arnold, M., 2018
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
NEJM 378:11-22,81, Nogueira, R.G.,et al, 2018
Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging
NEJM 378:708-718, Albers, G.W.,et al, 2018
Treatment and Outcome of Hemorrhagic Transformation after Intravenous Alteplase in Acute Ischemic Stroke
Stroke 48:e343-e361, Yaghi, S.,et al, 2017
Clinical Imaging Factors Associated with Infarct Progression in Patients with Ischemic Stroke During Transfer for Mechanical Thrombectomy
JAMA Neurol 74:1361-1367,1298, Boulouis, G.,et al, 2017
DAWN: Thrombectomy Effective Up to 24 Hours after Stroke
Medscape May, Hughes, S., 2017
Computed Tomographic Perfusion to Predict Response to Recanalization in Ischemic Stroke
Ann Neurol 81:849-856, Lansberg, M.G.,et al, 2017
Endovascular Treatment for Patients with Acute Stroke Who Have a Large Ischemic Core and Large Mismatch Imaging Profile
JAMA Neurol 74:34-40, Rebello, L.C.,et al, 2017
Coexistent Sickle Cell Disease has No Impact on the Safety or Outcome of Lytic Therapy in Acute Ischemic Stroke
Stroke 48:686-691, Adams, R.J.,et al, 2017
Thrombolytic Removal of Intraventricular Haemorrhage in Treatment of Severe Stroke: Results of the Randomised, Multicentre, Multiregion, Placebo-Controlled CLEAR III Trial
Lancet 389:603-611,575, Hanley, D.F.,et al, 2017
Reduction in Time to Treatment in Prehospital Telemedicine Evaluation and Thrombolysis
Neurol 88:1305-1312, Taqui, A.,et al, 2017
Clinical Relevance of Microbleeds in Acute Stroke Thrombolysis
Neurol 87:1534-1541, Charidimou, A.,et al, 2016
Treatment of Carotid Intramural Thrombus with TPA
JAMA Neurol 73:1496, Bennett, A.,et al, 2016
Drip and Ship Versus Direct to Comprehensive Stroke Center
Stroke 48:233-238, Holodinsky, J.K.,et al, 2016
Risk of Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis in Patients with Acute Ischemic Stroke and High Cerebral Microbleed Burden
JAMA Neurol 73:675-683,632, Tsivgoulis, G.,et al, 2016
And Why Not Thrombolysis in the Ambulance (At Least for Some)?
Neurol 87:214-219, Rosenberg, G. & Steiner, I., 2016
Repeated Intravenous Thrombolysis for Early Recurrent Stroke
Stroke 47:2133-2135, Kahles, T.,et al, 2016
Streamlined Hyeracute Magnetic Resonance Imaging Protocol Identifies Tissue-Type Plasminogen Activator-Eligible Stroke Patients When Clinical Impression is Stroke Mimic
Stroke 47:1012-1017, Goyal, M.S.,et al, 2016
Orolingual Angioedema During or After Thrombolysis for Cerebral Ischemia
Stroke 47:1825-1830, Myslimi, F.,et al, 2016
Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic STroke
Stroke 47:581-641, Demaerschalk, B.M.,et al, 2016
Intravenous Thrombolysis in Patients Dependent on the Daily Help of Others Before Stroke
Stroke 47:450-456, Gensicke, H.,et al, 2016
Telemedicine in Prehospital Stroke Evaluation and Thrombolysis
JAMA Neurol 73:162-168, Itrat, A.,et al, 2016
Carotid Near-Occlusion: A Comprehensive Review, Part 2- Prognosis and Treatment, Pathophysiology, Confusions, and Areas for Improvement
AJNR 37:200-204, Johansson, E. & Fox, A.J., 2016
IV Thrombolysis in very severe and severe ischemic stroke
Neurol 85:2098-2106, Mazyam, M.V.,et al, 2015
Endovascular Therapy is Effective and Safe for Patients with Severe Ischemic Stroke
Stroke 46:3416-3422, Broderick, J.P.,et al, 2015
IV Thrombolysis in Patients with Ischemic Stroke and Alcohol Abuse
Neurol 85:1592-1597, Gattringer, T.,et al, 2015
Cost-Utility Analysis of Mechanical Thrombectomy Using Stent Retrievers in Acute Ischemic Stroke
Stroke 46:2591-2598, Ganesalingam, J.,et al, 2015
Microbleed Status and 3-Month Outcome After Intravenous Thrombolysis in 717 Patients with Acute Ischemic Stroke
Stroke 46:2458-2463,2403, Turc, G.,et al, 2015
Treatment Concepts for Wake-Up Stroke and Stroke with Unknown Time of Symptom Onset
Stroke 46:2707-2713, Thomalla, G. & Gerloff, C., 2015
Intravenous Fibrinolytic Therapy in Central Retinal Artery Occlusion
JAMA Neurol 72:1148-1154, Schrag, M.,et al, 2015
Screening with MRI for Accurate and Rapid Stroke Treatment
Neurol 84:2438-2444, 2394, Shah, S.,et al, 2015
Immediate Hemorrhagic Transformation After Intravenous Tissue-Type Plasminogen Activator Injection in 2 Cocaine Users
Stroke 46:e167-e169, Baud, M.O.,et al, 2015
Implementing a Mobile Stroke Unit Program in the United States
JAMA Neurol 72:229-234, Rajan, S.,et al, 2015
Effects of Golden Hour Thrombolysis
JAMA Neurol 72:25-30,9, Ebinger, M.,et al, 2015
Safety of Intravenous Thrombolysis in Stroke Mimics
Stroke 46:1281-1287, Tsivgoulis, G.,et al, 2015
Hemi Orolingual Angioedema after tPA Administration for Acute Ischemic Stroke
West J Emerg Med 16:175-177, Madden, B. & Chebl, R.B., 2015
Brush Sign on 3-T T2* - Weighted MRI as a Potential Predictor of Hemorrhagic Transformation After Tissue Plasminogen Activator Therapy
Stroke 45:274-276, Terasawa, Y.,et al, 2014
Remote or Extraischemic Intracerebral Hemorrhage - An Uncommon Complication of Stroke Thrombolysis
Stroke 45:1657-1663, Mazya, M.V.,et al, 2014
Reperfusion Therapies for Wake-Up Stroke
Stroke 45:1869-1875, Buck, D.,et al, 2014
Safety of Thrombolysis in Patients with Acute Ischemic Stroke and Cerebral Cavernous Malformations
Stroke 45:1846-1848, Erdur, H.,et al, 2014
Symptomatic Intracerebral Hemorrhage in Acute Ischemic Stroke After Thrombolysis With Intravenous Recombinant Tissue Plasminogen Activator
JAMA Neurol 81:1181-1185, Yaghi, S.,et al, 2014
4.5-Hour Time Window for Intravenous Thrombolysis with Recombinant Tissue-Type Plasminogen Activator is Established Firmly
Stroke 45:912-913,916, Schellinger, P.D. & Kohrmann, M., 2014
The 4.5-HourTime Window for Intravenous Thrombolysis with Intravenous Tissue-Type Plasminogen Activator is Not Firmly Established
Stroke 45:915-915,916, Wechsler, L.R., 2014
Number of Cerebral Microbleeds and Risk of Intracerebral Hemorrhage after Intravenous Thrombolysis
Stroke 45:2900-2905, Dannenberg, S.,et al, 2014
Stroke and the Law
Stroke 45:3141-3146, Fisher, M. & Schneider, P., 2014
New Microbleeds after Thrombolysis
Medicine 93:e99, Yan, S.,et al, 2014
Alberta Stroke Program Early Computed Tomography Score to Select Patients for Endovascular Treatment
Stroke 45:444-449, Hill, M.D.,et al, 2014
Serum Creatinine May Indicate Risk of Symptomatic Intracranial Hemorrhage after Intravenous Tissue Plasminogen Activator (IV tPA)
Medicine 92:317-323, Marsh, E.B.,et al, 2013
IV Thrombolysis and Renal Function
Neurol 81:1780-1788, Gensicke, H.,et al, 2013